{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/croup/management/management/","result":{"pageContext":{"chapter":{"id":"3020718f-b53d-5af1-89e6-5a92a4c59075","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field 4c5cfd94-03ad-4f6b-a515-35a58eb53f37 --><h2>Scenario: Management</h2><!-- end field 4c5cfd94-03ad-4f6b-a515-35a58eb53f37 -->","summary":"Covers the management of croup in primary care.","htmlStringContent":"<!-- begin item c8fb8f44-b9d8-4718-a63b-78d841498265 --><!-- begin field dbfd0b3f-d248-4304-9f3a-acbc0158f1d1 --><p>From age 3 months to 6 years.</p><!-- end field dbfd0b3f-d248-4304-9f3a-acbc0158f1d1 --><!-- end item c8fb8f44-b9d8-4718-a63b-78d841498265 -->","topic":{"id":"ce03d247-afbe-5290-832f-8f95361dd16e","topicId":"663c3878-b65e-49df-b738-7711612b31ed","topicName":"Croup","slug":"croup","lastRevised":"Last revised in February 2019","chapters":[{"id":"147ea703-8a02-5151-abf9-289eb232d7f7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"b4d7d104-fefd-5285-8bf6-a20db31a3a6c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9b0196f5-c62f-557e-8c0b-8d5cdc4726b8","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"770a8563-687d-5b41-9629-8cdcd49a750a","slug":"changes","fullItemName":"Changes"},{"id":"10a53caf-873e-57a4-880d-aefdd5a5fb65","slug":"update","fullItemName":"Update"}]},{"id":"bf5dbb8f-554f-56b2-b8ce-62573dd2d938","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7d9ae47b-5ea9-557f-b53a-5bb9f9b69fcb","slug":"goals","fullItemName":"Goals"},{"id":"a5f272bf-bd65-5548-a253-2eece07472f4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b1168d32-0a16-5a45-844c-2f9e792cfccc","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"41533497-a783-5f26-98e4-554a82823d80","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"34edf552-026f-5c4d-b4ae-95034786ca88","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ba739830-6b73-555a-9c5f-3bf3e5ec3743","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0b7a2081-6723-53ae-9566-0481028ad175","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"467402a7-bf22-5f5b-8ad9-090c0b1b6be5","slug":"definition","fullItemName":"Definition"},{"id":"93d4df12-d240-53a9-bbc6-ad12f8363460","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0128d0fb-1a94-57dd-b210-2b011720efa2","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"0fa5d183-650e-5e12-a927-5e0bcff458bd","slug":"prognosis-complications","fullItemName":"Prognosis and complications"}]},{"id":"90baebc8-47bc-5144-a5ac-07ace34fe1d7","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b1189f4d-058a-54f6-83c8-43ed93b0d1ab","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"6c26580b-53cc-5db0-838c-71e5841fe898","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"efe34746-d360-5ce2-bdc6-4aab25a98130","fullItemName":"Management","slug":"management","subChapters":[{"id":"3020718f-b53d-5af1-89e6-5a92a4c59075","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"86c15ba0-c5cc-5a85-8d4c-490305d1540f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"76c755b1-a126-5291-8ae0-44276cfd3747","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"742b7beb-da22-597a-9bf5-35f9a3b8ff50","slug":"paracetamol-ibuprofen","fullItemName":"Paracetamol and ibuprofen"}]},{"id":"7ea6cbf9-fc01-56dd-8c9d-9b9cc1a69282","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c93aeb25-1189-5e59-bec3-5210121ed220","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f0d23dbb-0a01-5d60-9e6f-17bbf65083b3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"be9ee413-fa04-55ba-88df-d9606ca98a64","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d2337c68-6aec-522d-a1c5-329947299478","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"982ad0fa-2b63-5ea4-b6a3-200dca208aaa","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"86f92b32-a806-57d4-a00e-be2a234bfdee","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7b0c8a60-9bbe-5830-8e82-d9e6b1567c0b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"efe34746-d360-5ce2-bdc6-4aab25a98130","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"b2dac822-eff5-565a-8a94-d0bb24370b00","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 8da2b3e5-9685-44eb-a582-00b6ad778559 --><h3>How should I manage a person with croup?</h3><!-- end field 8da2b3e5-9685-44eb-a582-00b6ad778559 -->","summary":null,"htmlStringContent":"<!-- begin item 65416b3e-3da1-41e6-8f58-4d2c0c533e8b --><!-- begin field 099184d6-1c19-43e4-a002-dc51af491d1d --><ul><li><strong>Take care not to frighten the child as agitation can cause worsening of symptoms.</strong> To ensure comfort, the child should be seated comfortably in the parent/carer's lap.</li><li><strong>Categorise the severity of the symptoms:</strong><ul><li><strong>Mild </strong>–<strong> </strong>seal-like barking cough but no stridor or sternal/intercostal recession at rest.</li><li><strong>Moderate </strong>– seal-like barking cough with stridor and sternal recession at rest; no agitation or lethargy.</li><li><strong>Severe </strong>– seal-like barking cough with stridor and sternal/intercostal recession associated with agitation or lethargy.</li><li><strong>Impending respiratory failure </strong>– increasing upper airway obstruction, sternal/intercostal recession, asynchronous chest wall and abdominal movement, fatigue, pallor or cyanosis, decreased level of consciousness or tachycardia. The degree of chest wall recession may diminish with the onset of respiratory failure as the child tires.<ul><li>A respiratory rate of over 70 breaths/minute is also indicative of severe respiratory distress.</li></ul></li></ul></li><li><strong>Consider the need for hospital admission:</strong><ul><li>Admit all children with features of moderate or severe illness, or impending respiratory failure.</li><li>Hospital admission should also be considered for children with a respiratory rate of over 60 breaths/minute or who have a high fever or 'toxic' appearance.</li><li>Children with mild illness may require admission if they have factors that warrant a lower threshold for admission, such as:<ul><li>Chronic lung disease (including bronchopulmonary dysplasia).</li><li>Haemodynamically significant congenital heart disease.</li><li>Neuromuscular disorders.</li><li>Immunodeficiency.</li><li>Age under three months.</li><li>Inadequate fluid intake (50 to 75% of usual volume, or no wet nappy for 12 hours).</li><li>Factors that might affect a carer's ability to look after a child with croup, such as adverse social circumstances, or concerns about the skill and confidence of the carer in looking after a child with croup at home, or the carer being able to spot deteriorating symptoms.</li><li>Longer distance to healthcare in case of deterioration.</li></ul></li></ul></li><li><strong>While awaiting admission to hospital:</strong><ul><li>Give controlled supplementary oxygen to all children with symptoms of severe illness or impending respiratory failure.</li><li>Administer a dose of oral dexamethasone (0.15 mg/kg). If the child is too unwell to receive medication, inhaled budesonide (2 mg nebulised as a single dose) or intramuscular dexamethasone (0.6 mg/kg as a single dose) are possible alternatives.</li></ul></li><li><strong>If hospital admission is not required (mild illness):</strong><ul><li>Prescribe a single dose of oral dexamethasone (0.15 mg/kg) to be taken immediately.</li><li>Advise the parents/carers about the expected course of croup, including that symptoms usually resolve within 48 hours. Patient information leaflets are available from <a data-hyperlink-id=\"d377e27f-b9b8-4eb0-92c6-a99300495689\" href=\"https://patient.info/health/croup-leaflet\">Patient.info</a> and <a data-hyperlink-id=\"f61bb9df-c016-4e3e-b7f2-a993004957b6\" href=\"http://www.nhs.uk/conditions/Croup/Pages/Introduction.aspx\">NHS </a><a href=\"https://www.nhs.uk/conditions/\" data-hyperlink-id=\"20049736-877e-40cc-8ca3-aa5600d54e24\">A-Z</a>.</li><li>Advise them to take the child to hospital if stridor can be heard continually, the skin between the ribs is pulling in with every breath, and/or the child is restless or agitated.</li><li>Advise them to call an ambulance if the child is very pale, blue, or grey (includes blue lips) for more than a few seconds, is unusually sleepy or is not responding, is having a lot of trouble breathing (e.g., the belly is sinking in while breathing, or the skin between the ribs or over the windpipe is pulling in with each breath; the nostrils may also be flaring in and out), is upset (agitated or restless) while struggling to breathe and cannot be calmed down quickly, if they want to sit instead of lie down, and/or if they cannot talk, are drooling, or having trouble swallowing.</li><li>Provide self-care advice:<ul><li>Advise the parents/carers to use either paracetamol or ibuprofen to treat a child who is distressed due to fever. Antipyretic agents should not be used with the sole aim of reducing body temperature and should be continued for only as long as the child appears distressed.</li><li>Advise them to consider changing to the other agent if the child's distress is not alleviated, but not to give both agents simultaneously, and to only alternate these agents if the distress persists, or recurs before the next dose is due.</li><li>Advise them not attempt to reduce fever by under-dressing the child, or with use of tepid sponging.</li><li>Advise them to encourage the child to take fluids regularly. For infants that are breastfed, advise continued breastfeeding.</li><li>Advise the parents/ carers to check on the child regularly, including through the night.</li></ul></li><li>Arrange follow-up, using clinical judgment to determine the appropriate interval.</li></ul></li></ul><!-- end field 099184d6-1c19-43e4-a002-dc51af491d1d --><!-- end item 65416b3e-3da1-41e6-8f58-4d2c0c533e8b -->","subChapters":[{"id":"fb23eb8b-e265-5d43-911c-96c9911b3e90","slug":"basis-for-recommendation-033","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7a117b16-288e-4c40-9476-3ce88277b747 --><h4>Basis for recommendation</h4><!-- end field 7a117b16-288e-4c40-9476-3ce88277b747 -->","summary":null,"htmlStringContent":"<!-- begin item 033880b6-94af-42cb-ac3d-cbbbf6a0913b --><!-- begin field 674011d0-823b-4eb5-9ab1-3ec049cebf75 --><p>The information on management of a child with croup is largely based on expert opinion in the BMJ Best Practice guideline <em>Croup</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/croup/references/\">BMJ Best practice, 2017</a>] and what CKS considers to be appropriate best clinical practice.</p><h5>Hospital admission</h5><ul><li>The advice to admit all children with features of moderate or severe illness, or impending respiratory failure, is based on expert opinion that as well as corticosteroids, as a minimum, children in these groups require treatment with nebulised epinephrine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/croup/references/\">BMJ Best practice, 2017</a>].</li></ul><h5>Factors that lower the threshold for hospital admission and respiratory rate</h5><ul><li>The information on factors that lower the threshold for hospital admission in children with croup, and respiratory rate as an indicator of illness severity, is extrapolated from expert opinion relating to children with bronchiolitis within the National Institute of Health and Care Excellence (NICE) guideline <em>Bronchiolitis in children: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/croup/references/\">NICE, 2015</a>].</li></ul><h5>Oral dexamethasone dose</h5><ul><li>The advice to administer oral dexamethasone at a dosage of 0.15 mg/kg is based on evidence that this is as effective as the traditionally-used dose of 0.6 mg/kg [<a class=\"bibliography-reference internal-reference\" href=\"/topics/croup/references/\">BMJ Best practice, 2017</a>].</li></ul><h5>Self-care advice</h5><ul><li>The information on use of paracetamol and ibuprofen to treat fever, and intake of fluids, is based on expert opinion in the National Institute of Health and Care Excellence (NICE) guideline <em>Fever in under 5s: assessment and initial management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/croup/references/\">NICE, 2013</a>].</li></ul><h5>Monitoring a child being managed at home</h5><ul><li>The information on advising parents/ carers to check on the child regularly, including through the night, is extrapolated from expert opinion relating to children with bronchiolitis within the National Institute of Health and Care Excellence (NICE) guideline <em>Bronchiolitis in children: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/croup/references/\">NICE, 2015</a>].</li></ul><!-- end field 674011d0-823b-4eb5-9ab1-3ec049cebf75 --><!-- end item 033880b6-94af-42cb-ac3d-cbbbf6a0913b -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}